23/03/2026
We’re proud to share a major milestone for Cardiomyopathy UK 💜
For the first time, we are funding our own research grants.
Through our new Catalyst Grants programme, we are supporting two early-stage research projects in 2026:
🫀 a project exploring how AI could improve risk prediction in cardiomyopathy
🧬 a project investigating new treatment targets for hypertrophic cardiomyopathy (HCM) in children at risk
This marks an important step forward in our commitment to supporting the cardiomyopathy research community. By funding early-stage research, we can help researchers test promising ideas, build vital evidence and generate the momentum needed to attract further investment.
Just as importantly, people affected by cardiomyopathy helped shape the selection process. The projects we are funding reflect priorities identified through our Priority Setting Partnership, and applications were reviewed by both scientific experts and people with lived experience.
This means the research we support is shaped both by scientific expertise and by the real needs, experiences and priorities of the cardiomyopathy community.
We are incredibly excited to support these researchers and to see where their work leads. We are also deeply grateful to our supporters, whose generosity makes milestones like this possible.
🔗 Read more about our first research grants: https://www.cardiomyopathy.org/news-blogs/latest-news/cardiomyopathy-uk-awards-our-first-ever-research-grants
📩 Join our Research Network to hear the latest research news and opportunities to get involved: https://www.cardiomyopathy.org/form/research-network-subscribe